| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2428510 | F | Ratio of EC50 for wild type HIV1 ERS104pre to EC50 for multidrug-resistant HIV1 G harboring L10I/V11I/T12E/I15V/L19I/R41K/M46L/L63P/A71T/V82A/L90M protease-encoding region mutant | Human immunodeficiency virus 1 | 4 | organism-based format | Scientific Literature | ||
| 2. | ALA2428511 | F | Ratio of EC50 for wild type HIV1 ERS104pre to EC50 for multidrug-resistant HIV1 C harboring L10I/I15V/K20R/L24I/M36I/M46L/I54V/I62V/L63P/K70Q/V82A/L89M protease-encoding region mutant | Human immunodeficiency virus 1 | 4 | organism-based format | Scientific Literature | ||
| 3. | ALA2428513 | F | Antiviral activity against multidrug-resistant HIV1 G harboring L10I/V11I/T12E/I15V/L19I/R41K/M46L/L63P/A71T/V82A/L90M protease-encoding region mutant infected in human PHA-PBMC cells assessed as inhibition of p24 Gag protein production. | Human immunodeficiency virus 1 | 4 | organism-based format | Scientific Literature | ||
| 4. | ALA2428514 | F | Antiviral activity against multidrug-resistant HIV1 C harboring L10I/I15V/K20R/L24I/M36I/M46L/I54V/I62V/L63P/K70Q/V82A/L89M protease-encoding region mutant infected in human PHA-PBMC cells assessed as inhibition of p24 Gag protein production | Human immunodeficiency virus 1 | 4 | organism-based format | Scientific Literature | ||
| 5. | ALA2428515 | F | Antiviral activity against wild type HIV1 ERS104pre infected in human PHA-PBMC cells assessed as inhibition of p24 Gag protein production | Human immunodeficiency virus 1 | 4 | organism-based format | Scientific Literature | ||
| 6. | ALA2428633 | F | Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay | Human immunodeficiency virus 1 | 13 | organism-based format | Scientific Literature | ||
| 7. | ALA2428634 | B | Inhibition of HIV1 LAI protease by fluorescence assay | Human immunodeficiency virus 1 | 9 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!